90 related articles for article (PubMed ID: 3301026)
1. [Cyclosporin A in immunosuppressive therapy of kidney transplants (clinical results in 55 patients)].
Dean P; Boschiero L; Prati GF; Recchia G; Faccincani L; Turolla PJ; Firpo M
Chir Ital; 1987 Feb; 39(1):62-70. PubMed ID: 3301026
[TBL] [Abstract][Full Text] [Related]
2. Elective conversion from cyclosporin to azathioprine in living related donor kidney transplants.
Sobh MA; Eldein AB; Moustafa FE; Ghoneim MA
Nephrol Dial Transplant; 1987; 2(4):258-60. PubMed ID: 3118269
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A in renal transplantation: a prospective randomized trial.
Ferguson RM; Rynasiewicz JJ; Sutherland DE; Simmons RL; Najarian JS
Surgery; 1982 Aug; 92(2):175-82. PubMed ID: 6285533
[TBL] [Abstract][Full Text] [Related]
5. [14 years of kidney transplantation in children. Results with special reference to cyclosporin A treatment].
Brodehl J; Pichlmayr R; Offner G
Monatsschr Kinderheilkd; 1985 Oct; 133(10):771-3. PubMed ID: 3906380
[TBL] [Abstract][Full Text] [Related]
6. Improved patient and graft survival using cyclosporin A in cadaver renal transplantation.
Johnson RW
Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S81-5. PubMed ID: 3909587
[TBL] [Abstract][Full Text] [Related]
7. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
[No Abstract] [Full Text] [Related]
9. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation.
Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS
Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
[TBL] [Abstract][Full Text] [Related]
11. Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study.
Opelz G
Kidney Int Suppl; 1995 Dec; 52():S89-92. PubMed ID: 8587292
[TBL] [Abstract][Full Text] [Related]
12. Kidney transplantation from living donors: comparison of results between related and unrelated donor transplants under new immunosuppressive protocols.
Chkhotua AB; Klein T; Shabtai EL; Yussim A; Bar-Nathan N; Shaharabani E; Lustig S; Mor E
Isr Med Assoc J; 2003 Sep; 5(9):622-5. PubMed ID: 14509149
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
[TBL] [Abstract][Full Text] [Related]
14. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporin A: a powerful immunosuppressant.
Laupacis A; Keown PA; Ulan RA; McKenzie N; Stiller CR
Can Med Assoc J; 1982 May; 126(9):1041-6. PubMed ID: 7074504
[TBL] [Abstract][Full Text] [Related]
16. [Report of experiences on the use of cyclosporin A].
Konert J; Eismann R; Heinrichs HJ; Langkopf B
Z Gesamte Inn Med; 1988 Sep; 43(17):477-9. PubMed ID: 3070973
[TBL] [Abstract][Full Text] [Related]
17. Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression.
Merion RM; White DJ; Calne RY
Transplant Proc; 1983 Dec; 15(4):2172-7. PubMed ID: 6369690
[No Abstract] [Full Text] [Related]
18. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
Câmara NO; Dias MF; Pacheco-Silva A
Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
[TBL] [Abstract][Full Text] [Related]
19. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
Hourmant M; Soulillou JP
Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
[TBL] [Abstract][Full Text] [Related]
20. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
